EL7.AI
StocksMedium•17 November 2026•
4 min read

Abacus Delays Third-Quarter Report, Reviews Accounts Dating to 2025

Key Facts

1Abacus said on November 17 that it would be unable to file its quarterly report for the quarter ended September 30, 2026, on time.
2The review of prior reports could extend to June 30, 2025.
3The company said it could not estimate the scale of potential changes, including changes that could affect its November 5, 2026 results.
4Third-quarter revenue was $76.9 million, compared with $63.0 million a year earlier, and net income was $14.5 million, compared with $7.1 million.

Abacus Global Management said in a notice filed with the U.S. Securities and Exchange Commission on November 17 that it would be unable to file its quarterly report on time for the quarter ended September 30, 2026. The company attributed the delay to an ongoing accounting review covering capital account balances for limited partners in certain private funds it advises, as well as transactions with related-party funds. The balance review extends to periods beginning in the second quarter of 2025, while the company said it would assess whether prior periodic reports need correction. That assessment could reach back to reports for periods as of June 30, 2025. Law firm Block & Leviton announced on the same day that it was investigating possible securities law violations related to Abacus’s accounting and dealings with related-party funds.

Abacus said the capital account review concerns entries for amounts allocated to limited partners in certain private funds it manages or advises, and that the review period begins in the second quarter of 2025. The work also covers the accounting treatment of certain transactions between the company and related-party funds. After completing its assessment, the company will determine whether disclosures or figures in prior periodic reports need to be amended. The review could extend to periods ending June 30, 2025, according to the notice filed with the SEC. This means the potential impact of the review is not limited to the delayed quarterly report for the third quarter of 2026, but could also include figures published for earlier periods.

The company warned that the reexamination could significantly affect asset management revenue and certain related-party items. Among the items it cited were receivables related to limited partner incentives in the private funds. But it said it could not currently estimate the scale of any changes resulting from the review. Those could include figures in the third-quarter results statement the company issued on November 5. The results reported for that quarter therefore remain subject to change until the review is complete and the company determines whether corrections are required.

The review’s implications extend beyond financial figures to Abacus’s assessment of its control environment. The company said a reassessment of its controls could lead it to conclude that its disclosure controls and internal control over financial reporting were ineffective. The company did not say in the delay notice that it had reached that conclusion, but listed it as a possible outcome of the assessment. That possibility puts the integrity of its reporting and review procedures among the developments investors are awaiting. Whether prior reports need correction also remains tied to the findings of the ongoing review.

On November 5, Abacus reported third-quarter revenue of $76.9 million, compared with $63.0 million in the same period of 2025, and U.S. GAAP net income of $14.5 million, compared with $7.1 million. The company said the third-quarter figures were unaudited and could be affected by the review. In the same statement, it raised its estimate for full-year 2026 adjusted net income to a range of $104.5 million to $106.5 million. It also forecast adjusted earnings per share of between $0.28 and $0.30 for the fourth quarter, and between $1.05 and $1.07 for 2026. It later said in the delay notice that it could not estimate potential changes to figures it had previously reported, including the November 5 results.

Published data for the quarter ended September 30 show cash and cash equivalents of $104.0 million, while total outstanding debt, net of issuance costs and discounts, was $405.0 million. For the stock, EL7 data recorded Abacus’s closing price at $8.65 on November 16, the session before it filed the delay notice on November 17. The notice does not set a new deadline for filing the quarterly report, while the company said it would complete its assessment of the accounts, prior reports and internal controls. A review of the published results and determination of the scale of any potential adjustments remain pending completion of that work. Block & Leviton also announced an investigation into possible securities law violations; the announcement of an investigation does not mean that a lawsuit has been filed or that a violation has been established.

Open on chart